NIH Clinical Center: Search the Studies

Search the Studies

7 Studies found from all possible combinations of your search terms. Select a protocol that you wish to review.

Protocol Number	Title	Protocol Status	Min-Max Age	Institute	Keywords
21-C-0015	Phase II Trial Evaluating the Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment with Immune Checkpoint Inhibition (ICI) in Patients with Newly Diagnosed Glioblastoma or Gliosarcoma	Participants currently recruited/enrolled	18-125 Years	NCI	Gliosarcoma
20-C-0069	A First-In-Human Phase I Single-Agent Dose-Escalation, Food Effect and Dose Expansion Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms	Participants currently recruited/enrolled	18-125 Years	NCI	Gliosarcoma
20-C-0027	A Phase I Clinical Trial of Selinexor (KPT-330) in Combination with Temozolomide and Radiation Therapy in Patients with Newly Diagnosed Glioblastoma	Participants currently recruited/enrolled	18-125 Years	NCI	Gliosarcoma
17-C-0009	Phase I Trial of Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) plus Temozolomide versus Temozolomide alone in Adults with Recurrent Anaplastic Astrocytoma and Glioblastoma	Completed Study; data analyses ongoing	18-125 Years	NCI	Gliosarcoma
16-C-0081	A Phase I Dose Escalation Trial of Re-Irradiation in Good Prognosis Recurrent Glioblastoma	No longer recruiting/follow-up only	18-125 Years	NCI	Gliosarcoma
16-C-0034	A Phase II Trial of Oral Pazopanib plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) without Prior Bevacizumab Exposure and (B) after Failing Prior Bevacizumab	Completed Study; data analyses ongoing	18-125 Years	NCI	Gliosarcoma
15-C-0138	Phase I Study of Ipilimumab, Nivolumab, and the Combination in Patients with Newly Diagnosed Glioblastoma	Completed Study; data analyses ongoing	18-125 Years	NCI	Gliosarcoma